Advertisement

The Use of Quinolones for the Treatment of Shigellosis in Travelers

  • M. L. Bennish
Conference paper

Abstract

Shigellosis remains a major public health problem wherever sanitary conditions are poor. In developed countries, Shigella infections are most common in institutions for the mentally retarded, in day care centers, and among the poor. Examples of the latter are persons living in the inner cities or the Indian reservations of the United States where the incidence of shigellosis is much higher than for the general population [11].

Keywords

Nalidixic Acid Antimicrob Agent Minimum Inhibitory Concen Toxic Megacolon Indian Reservation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bennish ML, Eusof A, Kay B, Wierzba T (1985) Multiresistant Shigella infections in Bangladesh. Lancet 2: 441PubMedCrossRefGoogle Scholar
  2. 2.
    Benish ML, Harris JR, Wojtyniak BJ, Struelens M (1990) Death in shigellosis: incidence and risk factors in hospitalized patients. J Infect Dis 161: 500–506CrossRefGoogle Scholar
  3. 3.
    Bennish ML, Salam MA, Haider R, Barza M (1990) Therapy for shigellosis: II. Randomized double-blind comparison of ciprofloxacin and ampicillin. J Infect Dis 162: 7112–7116Google Scholar
  4. 4.
    Bennish ML, Azard AK,Yousefzadeh D (1991) Intestinal obstruction during shigellosis: incidence, clinical features, risk factors, and outcome. Gastroen-terology 101: 626–634Google Scholar
  5. 5.
    Centers for Disease Control (1986) Multiply resistant shigellosis in a daycare center, Texas. MMWR 35: 753–755Google Scholar
  6. 6.
    Centers for Disease Control (1987) Nationwide dissemination of multiply resistant Shigella sonnei following a common-source outbreak. MMWR 36: 633–634Google Scholar
  7. 7.
    Centers for Disease Control (1991) Shigella dysenteriae type 1 - Guatemala, 1991. MMWR 40: 421–428Google Scholar
  8. 8.
    DeMol P, Mets T, Lagasse R,Vandepitte J, Mutwewingabo A, Butzler J-P (1987) Treatment of bacillary dysentery: a comparison between enoxacin and nalidixic acid. J Antimicrob Chemother 19: 695–698CrossRefGoogle Scholar
  9. 9.
    DuPont HL, Levine MM, Hornick RB, Formal SB (1989) Inoculum size in shigellosis and implications for expected mode of transmission. J Infect Dis 159: 1126–1128PubMedCrossRefGoogle Scholar
  10. 10.
    Gotuzzo E, Oberhelman RA, Maguiña C, Berry SJ,Yi A, Guzman M, Ruiz R, Leon-Barua R, Sack RB (1989) Comparison of single-dose treatment with norfloxacin and standard 5-day treatment with trimethoprim-sulfamethoxazole for acute shigellosis in adults. Antimicrob Agents Chemother 33: 1101–1104Google Scholar
  11. 11.
    Keusch GT, Bennish ML (1991) Shigellosis. In: Evans AS, Brachman PS (eds) Bacterial infections of humans. Epidemiology and control. Plenum Press, New York, pp 593–620Google Scholar
  12. 12.
    Khan WA, Salam MA, Khan AM, Bennish ML (1991) Randomized, double-blinded comparison of short course ciprofloxacin with standard five day therapy in the treatment of severe shigellosis. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago. American Society for MicrobiologyGoogle Scholar
  13. 13.
    Koster F, Levin J, Walker L,Tunk KSK, Gilman RH, Rahaman MM, Majid MA, Islam S, Williams RC (1978) Hemolytic-uremic syndrome after shigellosis. Relation to endotoxemia and circulating immune complexes. N Engl J Med 298: 927–933Google Scholar
  14. 14.
    Parsonnet J, Greene KD, Gerber AR, Tauxe RV, Aguilar OCJ, Blake PA (1989) Shigella dysenteriae type 1 infections in US travellers to Mexico, 1988. Lancet 2: 543–546Google Scholar
  15. 15.
    Rogerie F, Ott D,Vandepitte J,Verbist L, Lemmens P, Habiyaremye I (1986) Comparison of norfloxacin and nalidixic acid for treatment of dysentery caused by Shigella dysenteriae type 1 in adults. Antimicrob Agents Chemother 29: 883–886PubMedGoogle Scholar
  16. 16.
    Ronsmans C, Bennish ML,WierzbaT (1988) Diagnosis and management of dysentery by community health workers. Lancet 2: 552–555Google Scholar
  17. 17.
    Salam MA, Bennish ML (1988) Therapy for shigellosis: 1. Randomized, double-blind trial of nalidixic acid in childhood shigellosis. J Pediatr 113: 901–907Google Scholar
  18. 18.
    Salam MA, Bennish ML (1991) Antimicrobial therapy for shigellosis. Rev Infect Dis 13 (Suppl 4): S332–341PubMedCrossRefGoogle Scholar
  19. 19.
    Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I (1991) Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. J Pediatr 118: 627–632PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • M. L. Bennish

There are no affiliations available

Personalised recommendations